Target intelligence / Profile preview

Norepinephrine (noradrenaline) (NE (commonly in the US); NA (in the UK))

Target
NE (commonly in the US); NA (in the UK)
Molecular classification
Catecholamine, Monoamine, Neurotransmitter, Hormone, Neuromodulator
01

Overview

Norepinephrine is an endogenous catecholamine that functions as a neurotransmitter, hormone, and neuromodulator in both the central and peripheral nervous systems[1][3][4][5]. It is a main mediator of the sympathetic "fight-or-flight" response, increasing heart rate, blood pressure, energy mobilization, and alertness[1][2][3][6]. Norepinephrine is synthesized in the locus coeruleus of the brain and released from sympathetic nerve endings, affecting nearly every organ system. It primarily signals through adrenergic (alpha and beta) G protein-coupled receptors[1][2][3][5]. Measurement of norepinephrine content is commonly used in clinical and research contexts to assess sympathetic activity or certain disease states, but the content itself is not a molecular target for drugs—rather, NE exerts its effects by acting on well-defined receptor targets. In summary: "Norepinephrine content" is *not* a canonical molecular target; the precise scientific entities are the molecule "norepinephrine" and its receptors or transporters[1][3][5][6].

Other names
NoradrenalineNANENoradrenalin
02

Mechanism of action

Agonism/antagonism of adrenergic receptors (alpha and beta) Inhibition of norepinephrine reuptake (SNRIs, TCAs) Inhibition of norepinephrine degradation (MAO inhibitors)

03

Biological functions

Signal transductionRegulation of arousal and alertnessRegulation of attention, memory formation and retrievalMediation of stress responses (fight-or-flight)Regulation of cardiovascular function (heart rate, blood pressure)Regulation of energy metabolism and glucose releaseImmune modulation
04

Disease associations

Cardiovascular disease (e.g., hypotension, shock)Neuropsychiatric disorders (e.g., depression, ADHD)Neurodegenerative disease (e.g., Parkinson’s disease)Stress-related disorders (e.g., PTSD, anxiety)
05

Safety considerations

Hypertension and increased cardiac workload (risk with NE as drug therapy)ArrhythmiasAnxiety, agitation, insomnia (with drugs increasing NE signaling)
06

Interacting drugs

Norepinephrine (as a drug in critical care/shock)

5 more in the full profile.

07

Biomarkers

Plasma norepinephrine levels (biomarker for sympathetic activity, pheochromocytoma, some forms of heart failure or shock)Cerebrospinal fluid NE (biomarker in neurological research)

Beyond the preview

Go deeper on Norepinephrine (noradrenaline) (NE (commonly in the US); NA (in the UK)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norepinephrine (noradrenaline) (NE (commonly in the US); NA (in the UK)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call